Wangyang Chen
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Isolinderalactone suppresses the progression of cholangiocarcinoma by modulating the CARMA1-BCL10-MALT1 signalosome.
Journal: The Journal of biological chemistry
Published: December 10, 2025
Securinine suppresses pancreatic cancer progression by activating the p38 MAPK pathway to upregulate CHOP and induce endoplasmic reticulum stress.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 18, 2025
Daurisoline inhibits pancreatic cancer progression by direct binding to PPARα and blocking its ubiquitination-mediated degradation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 08, 2025
Efficacy and safety of sequential cutting of nasobiliary tubes as an alternative to stent placement after nasobiliary drainage for the treatment of hilar malignant biliary stricture: a retrospective cohort study.
Journal: Therapeutic advances in gastroenterology
Published: November 17, 2024
Cucurbitacin C as an effective anti-cancer agent: unveiling its potential role against cholangiocarcinoma and mechanistic insights.
Journal: Journal of cancer research and clinical oncology
Published: June 21, 2023
Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 21, 2023
Linderalactone Suppresses Pancreatic Cancer Development In Vitro and In Vivo via Negatively Regulating PI3K/AKT Signaling Pathway.
Journal: Journal of oncology
Published: January 05, 2022
Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2/STAT3 signalling pathway in vivo and in vitro.
Journal: Journal of Cancer
Published: August 08, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026